Mimedic
Sources: the KBO register on 20-11-2026; the National Bank, 2025 annual accounts filed on 29-06-2026; the Belgian Official Gazette, latest deed of 18-02-2026.
Grounds
the facts the verdict rests on, each with its source- Mimedic made a profit in every financial year since 2023.Annual accounts 2023 to 2025 page 2
- Equity stands at €241,467, or 97.3% of the balance sheet total of €248,132.Annual accounts 2025 page 2
- Cash rose from €121,801 to €190,667. Debts due within one year fell from €8,328 to €6,665.Annual accounts 2024 and 2025 page 2
- The last three annual accounts came in on time. The 2025 accounts were filed 32 days before the end of the term.National Bank, filing of 29-06-2026 page 4
Representation
The signing rule is in the deed of 23-02-2023.
Articles of association, Belgian Official Gazette of 23-02-2023, deed 23316523
Ownership
holds all 100 shares.
Deed of 23-02-2023
Financial situation
Annual accounts 2023 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 202310 months | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Results | ||||
| Gross margin | €132,442 | €82,424 | €99,276 | |
| Operating result | €130,856 | €78,361 | €95,165 | |
| Net result | €102,356 | €62,052 | €74,059 | |
| Balance sheet at the closing date | ||||
| Equity | €105,356 | €167,408 | €241,467 | |
| Debts | €17,034 | €8,328 | €6,665 | |
| Debts due within one year | €17,034 | €8,328 | €6,665 | |
| Cash | €67,859 | €121,801 | €190,667 | |
| Balance sheet total | €122,390 | €175,735 | €248,132 | |
| Ratios | ||||
| Solvency | 86.1% | 95.3% | 97.3% | |
| Liquidity | 6.57 | 20.33 | 36.85 | |
Source: Annual accounts 2025, abbreviated format, filed on 29-06-2026 (2026-00216087); Annual accounts 2024, full format, filed on 20-06-2025 (2025-00165919); Annual accounts 2023, filed on 21-06-2024 (2024-00155753).
The operating result of 2025 is 21% higher than in 2024.
Debts fell by €1,662 in 2025.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
The financial year to 31-12-2023 ran for 10 months.
Board, signature and ownership
Position on 20-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 23-02-2023.
Articles of association, Belgian Official Gazette of 23-02-2023, deed 23316523
Board
one director in officeOwnership and group
Shareholders
holds all 100 shares.
Deed of 23-02-2023
Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 32 days before the deadline.
NBB filingCompany renamed from Docteur Urgentiste to Mimedic. Registered office moved within Ohey. The registered office moved from La Bouchaille 229, 5350 Ohey to Rue de l’Orgalisse, 31/3, 5354 Ohey (Jallet).
Gazette, deed 26311668Equity above €200,000. With a profit in every financial year since 2023, equity grows to €241,467.
FinancialAnnual accounts 2024 filed, 41 days before the deadline.
NBB filingWeakest financial year. The net result drops to €62,052, the lowest from 2023 to 2025. It recovers the following year.
FinancialLiquidity more than triples. The current ratio rises from 6.57 to 20.33. Short-term debt falls from €17,034 to €8,328.
FinancialEquity above €150,000. With a profit in every financial year since 2023, equity grows to €167,408.
FinancialComparable companies, two years later
In July 2024, 39,332 companies had the same profile as Mimedic has now: micro, 2 to 5 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 95.7% were still trading, 2.5% had stopped another way and 1.8% had gone bankrupt.
Other findings
Peppol
Reachable for e-invoices since 26-12-2025, under 0208:0798707205.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 20-11-2026 | KBO 0798.707.205 |
| National Bank of Belgium | Annual accounts 2025, abbreviated format | 29-06-2026 | 2026-00216087 |
| National Bank of Belgium | Annual accounts 2024, full format | 20-06-2025 | 2025-00165919 |
| National Bank of Belgium | Annual accounts 2023 to 2023 | 21-06-2024 | 2024-00155753 |
| Belgian Official Gazette | Articles of association with the signing rule | 23-02-2023 | deed 23316523 |
| Peppol Directory | Registration for e-invoices | 26-12-2025 | 0208:0798707205 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 20-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.